Elsevier

Neuroscience Letters

Volume 188, Issue 1, 16 March 1995, Pages 70-74
Neuroscience Letters

Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures

https://doi.org/10.1016/0304-3940(95)11384-9Get rights and content

Abstract

To investigate the role of IL-6 in the pathogenesis of Alzheimer's disease (AD) its effect on amyloid precursor protein (APP) mRNA expression was evaluated. The levels of APP mRNA were determined by Northern blot analysis in primary cultured rat cortical neurons and glial cells exposed to IL-6 (50–200 ng/ml). The cytokine increased neuronal APP mRNA expression about 100% at the highest dose after 6 h of exposure. APP mRNA expression was unaffected in astroglial cells exposed to IL-6. Since IL-1β also increased neuronal APP mRNA, the combination of IL-1β and IL-6 was tested. The effects were partially additive. The ability of β-amyloid fragment 25–35 to induce IL-1 or IL-6 mRNA was also investigated in astroglial cells. IL-1β mRNA was strongly induced by β25–35 (25–100 μM) while the expression of IL-6 mRNA remaining unchanged. The results suggest roles for both IL-1 and IL-6 in the neuronal mechanisms related to β-amyloid protein deposition in AD.

References (31)

  • J.D. Buxbaum et al.

    Cholinergic agonists and interleukin-1 regulate processing and secretion of the Alzheimer β/A4amyloid protein precursor

  • W.B. Ershler

    Interleukin-6: a cytokine for gerontologist

    J. Am. Geriatr. Soc.

    (1993)
  • G. Forloni et al.

    Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25–35

    NeuroReport

    (1993)
  • G. Forloni et al.

    A neurotoxic prion protein fragment induces rat astroglial proliferation and hypertrophy

    Eur. J. Neurosci.

    (1994)
  • L.R. French et al.

    A case-control study of dementia of the Alzheimer type

    Am. J. Epidemiol.

    (1985)
  • Cited by (175)

    • Inflammation in obesity, diabetes, and related disorders

      2022, Immunity
      Citation Excerpt :

      Because TREM2 is a receptor for a yet-to-be-identified lipid species, it is possible that activation of TREM2 with a ligand or an activating antibody could represent a potential therapeutic approach. Similar to macrophages throughout the body, activated microglia also release a number of cytokines that may participate in AD pathogenesis (Del Bo et al., 1995; Hanisch, 2002; Heneka et al., 2013, 2015b; Smith et al., 2012). IL-1β might be the most important cytokine released in this context and is elevated in the brains of AD patients (Liu and Quan, 2018).

    • 6-gingerol: A therapeutically potent lead candidate in anti-inflammatory drug discovery

      2019, Discovery and Development of Anti-inflammatory Agents from Natural Products
    • 6-Gingerol attenuates LPS-induced neuroinflammation and cognitive impairment partially via suppressing astrocyte overactivation

      2018, Biomedicine and Pharmacotherapy
      Citation Excerpt :

      Although reactive astrocytes are beneficial and important for maintaining homeostasis, it has been well demonstrated that overactivated astrocytes are detrimental in the brain [32–34]. Among the numerous proinflammatory cytokines, IL-6 is a pleiotropic interleukin and mainly synthesized and secreted by astrocytes [35]. Using IL-6 knockout mice, it has been demonstrated that IL-6 is an important mediator of LPS-induced cognitive deficits [36].

    View all citing articles on Scopus

    This work was supported by Consiglio Nazionale delle Ricerche, Rome, Italy, c.n. 93.0174.CT04 and Convenzione Psicofarmacologia.

    View full text